Non-immune salivary proteins-including lactoperoxidase, lysozyme, lactoferrin, and histatins-are key components of the innate host defense system in the oral cavity. Many antimicrobial proteins contain multiple functional domains, with the result that one protein may have more than one mechanism of antimicrobial activity. These domains may be separated by proteolytic cleavage, creating smaller proteins with functional antimicrobial activity in saliva as described for lysozyme, lactoferrin, and histatins. These small cationic proteins then exert cytotoxic activity to oral bacteria and fungi. Salivary histatin 5 initiates killing of C. albicans through binding to yeast membrane proteins and non-lytic release of cellular ATP. Extracellular ATP may then activate fungal ATP receptors to induce ultimate cell death. This mechanism for fungal cytotoxicity may be shared by other antimicrobial cationic proteins. Microbicidal domains of salivary and host innate proteins should be considered as potential therapeutic agents in the oral cavity.
Bellamy W., Takase M., Wakabayashi H., Kawase K., Tomita M. (1992a). Antibacterial spectrum of lactoferricin B, a potent peptide derived from the N-terminal of bovine lactoferrin. J Appl Bacteriol73:472-479.
2.
Bellamy W., Takase M., Yamauchi K., Wakabayashi H., Kawase K., Tomita M. (1992b). Identification of the bactericidal domain of lactoferrin. Biochim Biophys Acta1121:130-136.
3.
Bellamy W., Wakabayashi H., Takase M., Kawase K., Shimamura S., Tomita M. (1993). Killing of Candida albicans by lactoferricin B, a potent antimicrobial peptide derived from the N-terminal region of bovine lactoferrin. Med Microbiol Immunol182:97-105.
4.
Bourdineaud J., Fierobe H., Lazdunski C., Pages J. (1990). Involvement of OmpF during reception and translocation steps of colicin N entry. Mol Microbiol4:1737-1743.
5.
Boyum R., Guidotti G. (1997). Glucose-dependent, cAMP-mediated ATP efflux from S. cerevisiae. Microbiology143:1901-1908.
6.
Calderone R., Braun P. (1991). Adherence and receptor relationships of Candida albicans. Microbiol Rev55:1-20.
7.
Cannon RD, Holmes AR, Mason AB, Monk BC ( 1995). Oral candida: clearance, colonization or candidiasis?J Dent Res74:1152-1161.
8.
Chapple DS, Joannou CL, Mason DJ, Shergill JK, Odell EW, Gant V., et al. (1998). A helical region on human lactoferrin. Its role in antibacterial pathogenesis. Adv Exp Med Biol443:215-220.
9.
Colman R. (1990). Aggregin: a platelet ADP receptor that mediates activation. FASEB J4:1425-1435.
10.
Di Virgilio F. (1995). The P2Z purinoreceptor: an intriguing role in immunity, inflammation and cell death. Immunol Today16:524-528.
11.
During K., Porsch P., Mahn A., Brinkmann O., Werner G. (1999). The non-enzymatic microbicidal activity of lysozymes . FEBS Lett449:93-100.
12.
Edgerton M., Koshlukova SE, Lo TE, Chrzan BG, Straubinger RM, Raj PA (1998). Candidacidal activity of salivary histatins: identification of a histatin 5-binding protein on Candida albicans. J Biol Chem273:20438-20447.
13.
Edgerton M., Koshlukova SE, Araujo MW, Patel RC, Dong J., Bruenn JA (2000). Salivary histatin 5 and human neutrophil defensin 1 kill Candida albicans via shared pathways. Antimicrob Agents Chemother44:3310-3316.
14.
Gabay JE (1994). Ubiquitous natural antibiotics. Science264 :373-374.
15.
Georgopapadakou NH, Walsh TJ (1994). Human mycoses: drugs and targets for emerging pathogens. Science264:371-375.
16.
Helmerhorst EJ, Breeuwer P., van 't Hof W., Walgreen-Weterings E., Oomen Lcjm, Veerman ECI, et al. (1999a). The cellular target of histatin 5 on Candida albicans is the energized mitochondrion. J Biol Chem274:7286-7291.
17.
Helmerhorst EJ, Hodgson R., van 't Hof W., Veerman EC, Allison C., Nieuw Amerongen AV (1999b). The effects of histatin-derived basic antimicrobial peptides on oral biofilms. J Dent Res78 :245-250.
18.
Hoek KS, Milne JM, Grieve PA, Dionysius DA, Smith R. (1997). Antibacterial activity of bovine lactoferrin-derived peptides. Antimicrob Agents Chemother43:54-59.
19.
Hoffmann JA, Kafatos FC, Janeway CA, Ezekowitz RAB (1999). Phylogenetic perspectives in innate immunity. Science284:1313-1318.
20.
Holbrook IB, Molan PC (1975). The identification of a peptide in human parotid saliva particularly active in enhancing the glycolytic activity of the salivary micro-organisms. Biochem J149:489-492.
21.
Jainkittivong A., Johnson DA, Yeh CK (1998). The relationship between salivary histatin levels and oral yeast carriage. Oral Microbiol Immunol13:181-187.
22.
Kang JH, Lee MK, Ki KL, Hahm K.-S (1996). Structure-biological activity relationships of 11-residue highly basic peptide segment of bovine lactoferrin. Int J Peptide Protein Res48:357-363.
23.
Kato T., Takahashi N., Kuramitsu HK (1992). Sequence analysis and characterization of the Porphyromonas gingivalis prtC gene, which expresses a novel collagenase activity . J Bacteriol174:3889-3895.
24.
Koshlukova SE, Lloyd TL, Araujo MWB, Edgerton M. (1999). Salivary histatin 5 induces non-lytic release of ATP from Candida albicans leading to cell death. J Biol Chem274 :18872-18879.
25.
Koshlukova SE, Araujo MW, Baev D., Edgerton M. (2000). Released ATP is an extracellular cytotoxic mediator in salivary histatin 5-induced killing of Candida albicans. Infect Immun68:6848-6856.
26.
Kuwata H., Yip T.-T, Yip CL, Tomita M., Hutchens TW (1998). Direct evidence of the generation in human stomach of an antimicrobial domain (lactoferrin) from ingested lactoferrin. Biochim Biophys Acta1429:129-141.
27.
Laible NJ, Germaine GR (1985). Bactericidal activity of human lysozyme, muramidase-inactive lysozyme, and cationic polypeptides against Streptococcus sanguis and Streptococcus faecalis: inhibition by chitin oligosaccharides. Infect Immun48:720-728.
28.
Lenander-Lumikari M. (1992). Inhibition of Candida albicans by the peroxidase/SCN-/H2O2 system. Oral Microbiol Immunol7 :315-320.
29.
Lieberthal W., Menza S., Levine J. (1998). Graded ATP depletion can cause necrosis or apoptosis of cultured mouse proximal tubular cells. Am J Physiol274:F315-F327.
30.
Lumikari M., Soukka T., Nurmio S., Tenovuo J. (1991). Inhibition of the growth of Streptococcus mutans, Streptococcus sobrinus and Lactobacillus casei by oral peroxidase systems in human saliva. Arch Oral Biol36:155-160.
31.
MacKay BJ, Denepitiya L., Iacono VJ, Krost SB, Pollock JJ (1984). Growth-inhibitory and bactericidal effects of human parotid salivary histidine-rich polypeptides on Streptococcus mutans . Infect Immun44:695-701.
32.
Mikola H., Waris M., Tenovuo J. (1995). Inhibition of herpes simplex virus type 1, respiratory syncytial and echo virus by peroxidase-generated hypothiocyanite. Antiviral Res26 :161-171.
33.
Murakami Y., Nagata H., Amano A., Takagaki M., Shizukuishi S., Tsunemitsu A., et al. (1991a). Inhibitory effects of human salivary histatins and lysozyme on coaggregation between Porphyromonas gingivalis and Streptococcus mitis. Infect Immun59:3284-3286.
34.
Murakami Y., Shizukuishi S., Tsunemitsu A., Nakashima K., Kato Y., Aimoto S. (1991b). Binding of a histidine-rich peptide to Porphyromonas gingivalis. FEMS Microbiol Lett66:253-256.
35.
Odell EW, Sarra R., Foxworthy M., Chapple DS, Evans RW (1996). Bactericidal activity of peptides homologous to a loop region in human lactoferrin. FEBS Lett382:175-178.
36.
Oppenheim FG, Xu T., McMillian FM, Levitz SM, Diamond RD, Offner GD, et al. (1988). Histatins, a novel family of histidine-rich proteins in human parotid secretion. J Biol Chem263:7472-7477.
37.
Prasad R., Wergifosse P., Goffeau A., Balzi E. (1995). Molecular cloning and characterization of a novel gene of C. albicans, CDR1, conferring multiple resistance to drugs and antifungals . Curr Genet27:320-329.
38.
Raj PA, Edgerton M., Levine MJ (1990). Salivary histatin 5-dependence of sequence, chain length and helical conformation for candidacidal activity. J Biol Chem265 :3898-3905.
39.
Raj PA, Marcus E., Sukumaran DK (1998). Structure of human salivary histatin 5 in aqueous and nonaqueous solutions. Biopolymers45:51-67.
40.
Roman RM, Wang Y., Lidofsky SD, Feranchak AP, Lomri N., Scharschmidt BF, et al. (1997). Hepatocellular ATP-binding cassette protein expression enhances ATP release and autocrine regulation of cell volume. J Biol Chem272 :21970-21976.
41.
Schwiebert EM, Egan ME, Hwang T.-H, Fulmer SB, Allen SS, Cutting GR, et al. (1995). CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATP. Cell81:1063-1073.
42.
Sugiyama K., Suzuki Y., Furuta H. (1985). Isolation and characterization of histamine-releasing peptides from human parotid saliva. Life Sci37:475-480.
43.
Taylor DC, Cripps AW, Clancy RL (1995). A possible role for lysozyme in determining acute exacerbation in chronic bronchitis. Clin Exp Immunol102:406-416.
44.
Tenovuo J. (1989). Nonimmunoglobin defense factors in human saliva . In: Human saliva: clinical chemistry and microbiology. Vol. 2. Tenovuo JO, editor. Boca Raton, FL: CRC Press, pp. 55-91.
45.
Thomas EL, Milligan TW, Joyner RE, Jefferson MM (1994). Antibacterial activity of hydrogen peroxide and the lactoperoxidase-hydrogen peroxide-thiocyanate system against oral streptococci . Infect Immun62:529-535.
46.
Tsai H., Bobek LA (1997). Human salivary histatin-5 exerts potent fungicidal activity against Cryptococcus neoformans. Biochim Biophys Acta1336:367-369.
47.
Tsai H., Raj PA, Bobek LA (1996). Candidacidal activity of recombinant salivary histatin-5 and variants. Infect Immun64:5000-5007.
48.
Wakabayashi H., Hiratani K., Uchida K., Yamaguchi H. (1996). Antifungal spectrum and fungicidal mechanism of an N-terminal peptide of bovine lactoferrin. J Infect Chemother1:185-189.
49.
Wu T., Samaranayake LP, Leung WK, Sullivan PA (1999). Inhibition of growth and secreted aspartyl proteinase production in Candida albicans by lysozyme. J Med Microbiol48:721-730.
50.
Xu TS, Levitz M., Diamond RD, Oppenheim FG (1991). Anticandidal activity of major salivary histatins . Infect Immun70:2549-2554.
51.
Xu Y., Ambudkar I., Yamagishi H., Swaim W., Walsh TJ, O'Connell BC (1999). Histatin 3-mediated killing of Candida albicans: effect of extracellular salt concentration on binding and internalization . Antimicrob Agents Chemother43 :2256-2262.
52.
Yeh CK, Dodds MW, Zuo P., Johnson DA (1997). A population-based study of salivary lysozyme concentrations and candidal counts. Arch Oral Biol42:25-31.
